Skip to main content
Porton Pharma Solutions Ltd. logo

Porton Pharma Solutions Ltd. — Investor Relations & Filings

Ticker · 300363 ISIN · CNE100001S57 LEI · 300300IQTJFHA0YRXE68 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,163 across all filing types
Latest filing 2025-08-22 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 300363

About Porton Pharma Solutions Ltd.

https://www.porton.cn

Porton Pharma Solutions Ltd. is a global contract development and manufacturing organization (CDMO) providing end-to-end solutions for the pharmaceutical and biotechnology sectors. The company specializes in the development and manufacturing of small molecule APIs, intermediates, and drug products, while expanding its capabilities into biologics and cell and gene therapies. Its service portfolio encompasses process research and development, analytical services, pilot-scale production, and large-scale commercial manufacturing. Porton operates a network of R&D centers and manufacturing facilities designed to meet international regulatory standards, including those of the FDA and EMA. By leveraging an integrated technology platform, the company supports clients throughout the entire drug lifecycle, from preclinical development to commercialization, focusing on operational excellence and supply chain security.

Recent filings

Filing Released Lang Actions
董事会审计委员会议事规则（2025年8月）
Governance Information Classification · 95% confidence The document is titled '董事会审计委员会议事规则' which translates to 'Board Audit Committee Meeting Rules' and is dated August 2025. It details the composition, responsibilities, powers, meeting procedures, and operational rules of the Audit Committee of the Board of Directors of Chongqing Boteng Pharmaceutical Technology Co., Ltd. The content focuses on governance structure, audit oversight, internal control supervision, and committee procedural rules. There are no financial statements, earnings data, or report disclosures. It is a governance-related document outlining internal rules and committee functions rather than a financial report or announcement. Therefore, it fits best under Governance Information (CGR).
2025-08-22 Chinese
董事会多元化政策（2025年8月)
Governance Information Classification · 95% confidence The document is titled '董事会多元化政策' which translates to 'Board Diversity Policy' and outlines the company's policy on board diversity, including measurable targets and oversight. It references governance structure, board nomination committee responsibilities, and disclosure in the company's annual and ESG reports. There is no financial data, earnings information, or regulatory filing content. The document is a governance-related policy statement issued by the board. Therefore, it fits best under Governance Information (CGR). The document length is short and it is not an announcement of a report but a policy document itself.
2025-08-22 Chinese
总经理工作细则（2025年8月）
Governance Information Classification · 95% confidence The document is titled '总经理工作细则' which translates to 'General Manager Work Rules' or 'General Manager Work Procedures'. It details the roles, responsibilities, appointment, dismissal, and evaluation of the company's general manager and other senior management personnel. It includes internal governance rules and procedures related to management but does not contain financial statements, audit information, or regulatory filings. There is no indication that this is a report or announcement of financial results, capital changes, or legal proceedings. It is a governance-related document focusing on management structure and internal rules. Therefore, the most appropriate classification is Governance Information (CGR). The document length is sufficient and it is not a brief announcement or certification, so it is not RNS or RPA. Confidence is high due to clear content focus on governance and management rules.
2025-08-22 Chinese
独立董事工作制度（2025年8月）
Governance Information Classification · 100% confidence The document is titled '独立董事工作制度' which translates to 'Independent Director Work System'. It details the governance structure, roles, responsibilities, nomination, election, and duties of independent directors within the company. It references laws, regulations, and company bylaws related to corporate governance and independent directors. There is no financial data, earnings information, or report publication mentioned. The content is focused on governance practices and internal rules regarding board members, specifically independent directors. Therefore, this document fits the category of Governance Information (CGR). The document length is substantial (8795 characters), indicating it is a full governance policy document rather than a brief announcement or summary.
2025-08-22 Chinese
董事会议事规则（2025年8月）
Governance Information Classification · 95% confidence The document is titled "董事会议事规则" which translates to "Rules of Procedure for the Board of Directors" of 重庆博腾制药科技股份有限公司. It details the composition, duties, rights, meeting procedures, and governance rules of the company's board of directors. It does not contain financial statements, audit opinions, or earnings data. It is a governance document outlining internal rules and board structure. Therefore, it fits the category of Governance Information (CGR). The document length is substantial and it is not an announcement or a brief notice, so it is not a report publication announcement or regulatory filing. Hence, the classification is CGR with high confidence.
2025-08-22 Chinese
董事会提名委员会议事规则（2025年8月）
Governance Information Classification · 100% confidence The document is titled '董事会提名委员会议事规则' which translates to 'Board Nomination Committee Rules'. It details the structure, responsibilities, and procedures of the nomination committee within the board of directors of the company. It references company governance, appointment and nomination of directors and senior management, and compliance with relevant laws and regulations. There is no financial data, no report of financial results, no voting results, no announcement of dividends, no legal proceedings, no capital changes, and no mention of any report publication. The content is focused on governance practices and internal board committee rules, which fits the category of Governance Information (CGR). The document length is 2406 characters, which is relatively short but contains substantive governance rules rather than a mere announcement. Therefore, the appropriate classification is Governance Information (CGR).
2025-08-22 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.